142 related articles for article (PubMed ID: 33465790)
1. Malignant Uterine Neoplasms Attended at a Brazilian Regional Hospital: 16-years Profile and Time Elapsed for Diagnosis and Treatment.
Candido EC; Veiga Junior NN; Minari MP; Toledo MCS; Yela DA; Teixeira JC
Rev Bras Ginecol Obstet; 2021 Feb; 43(2):137-144. PubMed ID: 33465790
[TBL] [Abstract][Full Text] [Related]
2. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and surgical therapy of uterine sarcoma.
Vrzic-Petronijevic S; Likic-Ladjevic I; Petronijevic M; Argirovic R; Ladjevic N
Acta Chir Iugosl; 2006; 53(3):67-72. PubMed ID: 17338203
[TBL] [Abstract][Full Text] [Related]
4. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
5. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.
Hu S; Hinson JL; Matnani R; Cibull ML; Karabakhtsian RG
Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301
[TBL] [Abstract][Full Text] [Related]
6. Outcome of uterine clear cell carcinomas compared to endometrioid carcinomas and poorly-differentiated endometrioid carcinomas.
Petignat P; Usel M; Gauthier P; Popowski Y; Pelte MF; Bouchardy C; Verkooijen HM
Eur J Gynaecol Oncol; 2008; 29(1):57-60. PubMed ID: 18386465
[TBL] [Abstract][Full Text] [Related]
7. Well differentiated endometrioid adenocarcinoma of the uterus: a cancer unit or centre case?
Montalto SA; Hakmi A; Moth P; Raju KS; Coutts M; Papadopoulos AJ; Devaja O
Eur J Gynaecol Oncol; 2009; 30(1):35-9. PubMed ID: 19317254
[TBL] [Abstract][Full Text] [Related]
8. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
[TBL] [Abstract][Full Text] [Related]
9. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
10. A clinical and biological comparison between malignant mixed müllerian tumors and grade 3 endometrioid endometrial carcinomas.
Bland AE; Stone R; Heuser C; Shu J; Jazaeri A; Shutter J; Atkins K; Rice L
Int J Gynecol Cancer; 2009 Feb; 19(2):261-5. PubMed ID: 19396006
[TBL] [Abstract][Full Text] [Related]
11. The influence of early diagnosis of endometrioid endometrial cancer on disease stage and survival.
Barak F; Kalichman L; Gdalevich M; Milgrom R; Laitman Y; Piura B; Lavie O; Gemer O
Arch Gynecol Obstet; 2013 Dec; 288(6):1361-4. PubMed ID: 23695509
[TBL] [Abstract][Full Text] [Related]
12. Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis.
Isrow D; Burmeister C; Hanna RK; Elshaikh MA
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():115-120. PubMed ID: 27838535
[TBL] [Abstract][Full Text] [Related]
13. Does iatrogenic tumor rupture during surgery have prognostic implications for the outcome of uterine sarcomas?
Benito V; Lubrano A; León L; Molano F; Pinar B
Int J Gynecol Cancer; 2020 Nov; 30(11):1726-1732. PubMed ID: 32948637
[TBL] [Abstract][Full Text] [Related]
14. A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.
Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W
Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676
[TBL] [Abstract][Full Text] [Related]
15. Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.
Fader AN; Java J; Tenney M; Ricci S; Gunderson CC; Temkin SM; Spirtos N; Kushnir CL; Pearl ML; Zivanovic O; Tewari KS; O'Malley D; Hartenbach EM; Hamilton CA; Gould NS; Mannel RS; Rodgers W; Walker JL
Gynecol Oncol; 2016 Dec; 143(3):460-465. PubMed ID: 27743738
[TBL] [Abstract][Full Text] [Related]
16. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.
Rabban JT; Gilks CB; Malpica A; Matias-Guiu X; Mittal K; Mutter GL; Oliva E; Parkash V; Ronnett BM; Staats P; Stewart CJR; McCluggage WG
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S25-S39. PubMed ID: 30550482
[TBL] [Abstract][Full Text] [Related]
17. Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome.
Gayar OH; Robbins JR; Parikh K; Lu M; Buekers T; Munkarah A; Elshaikh MA
Gynecol Oncol; 2011 Oct; 123(1):71-5. PubMed ID: 21767871
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors relating to survival in uterine endometrioid carcinoma.
Hirai M; Hirono M; Oosaki T; Hayashi Y; Yoshihara T; Matsuzaki O
Int J Gynaecol Obstet; 1999 Aug; 66(2):155-62. PubMed ID: 10468339
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic of uterine sarcoma, review of 11 cases].
Cárdenas-Serrano ÓE; Villalón-López JS; Ruiz-Mar G; Daza-Benítez L
Ginecol Obstet Mex; 2015 Sep; 83(9):515-21. PubMed ID: 26591039
[TBL] [Abstract][Full Text] [Related]
20. The outcomes of 27,063 women with unstaged endometrioid uterine cancer.
Chan JK; Wu H; Cheung MK; Shin JY; Osann K; Kapp DS
Gynecol Oncol; 2007 Aug; 106(2):282-8. PubMed ID: 17662377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
